Press release
Electrochemical Biosensors Market Size, Status and Forecast 2025; by Application and End User
In addition, POCT testing offers various advantages such as cost reduction for laboratory testing, faster results, and increased patient satisfaction. Hence, increasing demand of point of care testing would drive the growth of biosensors market.
Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/2792 .
Key players in the electrochemical biosensors:
Key players in the automated devices market are F. Hoffmann-La Roche AG (Germany), Medtronic Plc. (U.S.), Bayer AG (Germany), Abbott (U.S.), I-SENS, Inc. (South Korea), Siemens (U.S.) and others. The main focus of these players is tapping the market in developing regions across the globe. Also product differentiation plays an important role for sustaining the growth of key players in the market.
Key developments:
Hoffmann-La Roche AG:
Headquartered in Basel, Switzerland; F. Hoffmann-La Roche AG is a company manufacturing and marketing number of innovative diagnostic tests and medicines, across the globe. The company offers various products in the pharmaceutical, diagnostics and research industry.
June, 2017: F. Hoffmann-La Roche AG acquired mySugr to form a leading platform for digital diabetes management
August, 2015: F. Hoffmann-La Roche AG acquired GeneWEAVE to strengthen offerings in microbiology diagnostics. Roche will pay GeneWEAVE shareholders $190 million upfront and up to USD 235 million in contingent product related milestones
February 2015 : F. Hoffmann-La Roche AG announced the collaboration with BioMed X for the development of Nanomaterial-Based Biosensors for Near-Patient Testing
September 2014: F. Hoffmann-La Roche AG launched Elecsys anti-Müllerian Hormone (AMH) fertility test for assessment of ovarian reserve for pregnancy
Medtronic plc.
Founded in 1949, Medtronic plc is a global healthcare solutions company committed to improving the lives of people through their medical technologies, services, and solutions.
Order Copy of 73 Premium Pages is Available @ https://www.marketresearchfuture.com/order_form.pdf?report_id=2792 .
October, 2016: Medtronic plc received an approval for its suite of cardiac rhythm and heart failure devices and leads to be scanned in both 3 and 1.5 Tesla (T) magnetic resonance imaging (MRI) machines. This FDA approval will help the company to strengthen its position in MRI machines segment.
December, 2015: Medtronic plc and Samsung came together in an alliance to accelerate the development of digital health solutions for the millions of people suffering from chronic pain, movement disorders, incontinence, and other conditions who could benefit from neuromodulation therapy. Due to this Medtronics seeks to deliver real-time data to the patients and the physicians so they effectively find the cure for the tracked symptoms.
Abbott:
Headquartered in Illinois, USA, Abbott focuses on discovery, development, manufacture, and sale of health care products. The company operates through four segments namely, established pharmaceutical products, diagnostic products, nutritional products, and vascular products. Additionally, the company has two non-reportable segments, namely, diabetes care and medical optics. The diabetes care division of the company is located in California, U.S. and provides blood glucose meters, blood glucose test strips, sensors, data management decision software, and accessories.
June, 2017: Alere shareholders approve amended merger with Abbott. This merger will further strengthen the global presence of the company.
October, 2016 : Abbott announced collaborations with Celgene and Agios for diagnostic identification of IDH mutations. The agreement focuses on the development and commercialize the diagnostic tests.
April, 2016: Abbott received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.
Siemens:
Siemens is a leading global healthcare company continuously developing their portfolio from medical imaging and laboratory diagnostics to adding managed services, consulting, and healthcare IT services apart from further technologies for therapeutic and molecular diagnostics.
September, 2016: Siemens launched the combination of the Modularis urological shock wave unit and the flat detector technology of the mobile C-arm Cios Fusion. Since, constantly switching between two or even three different control units would be complicated and could lead to errors, the Modularis' central control unit is a better option. This will help Siemens to strengthen its position in the market.
Ask to Expert @ https://www.marketresearchfuture.com/enquiry/2792 .
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Increasing diabetic population, rising prevalence of chronic and lifestyle diseases, and increasing demand for point-of-care-testing (POCT) devices are major factors contributing to the growth of the market. Additionally, increasing application of biosensors in various industries also accelerates the growth of the market. However, the market growth is restrained by various factors such as strict regulatory requirements, reimbursement policies issues in healthcare systems. The Global Electrochemical Biosensors Market is growing at the CAGR of 9.7%.
In addition, POCT testing offers various advantages such as cost reduction for laboratory testing, faster results, and increased patient satisfaction. Hence, increasing demand of point of care testing would drive the growth of biosensors market.
Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/2792 .
Key players in the electrochemical biosensors:
Key players in the automated devices market are F. Hoffmann-La Roche AG (Germany), Medtronic Plc. (U.S.), Bayer AG (Germany), Abbott (U.S.), I-SENS, Inc. (South Korea), Siemens (U.S.) and others. The main focus of these players is tapping the market in developing regions across the globe. Also product differentiation plays an important role for sustaining the growth of key players in the market.
Key developments:
Hoffmann-La Roche AG:
Headquartered in Basel, Switzerland; F. Hoffmann-La Roche AG is a company manufacturing and marketing number of innovative diagnostic tests and medicines, across the globe. The company offers various products in the pharmaceutical, diagnostics and research industry.
June, 2017: F. Hoffmann-La Roche AG acquired mySugr to form a leading platform for digital diabetes management
August, 2015: F. Hoffmann-La Roche AG acquired GeneWEAVE to strengthen offerings in microbiology diagnostics. Roche will pay GeneWEAVE shareholders $190 million upfront and up to USD 235 million in contingent product related milestones
February 2015 : F. Hoffmann-La Roche AG announced the collaboration with BioMed X for the development of Nanomaterial-Based Biosensors for Near-Patient Testing
September 2014: F. Hoffmann-La Roche AG launched Elecsys anti-Müllerian Hormone (AMH) fertility test for assessment of ovarian reserve for pregnancy
Medtronic plc.
Founded in 1949, Medtronic plc is a global healthcare solutions company committed to improving the lives of people through their medical technologies, services, and solutions.
Order Copy of 73 Premium Pages is Available @ https://www.marketresearchfuture.com/order_form.pdf?report_id=2792 .
October, 2016: Medtronic plc received an approval for its suite of cardiac rhythm and heart failure devices and leads to be scanned in both 3 and 1.5 Tesla (T) magnetic resonance imaging (MRI) machines. This FDA approval will help the company to strengthen its position in MRI machines segment.
December, 2015: Medtronic plc and Samsung came together in an alliance to accelerate the development of digital health solutions for the millions of people suffering from chronic pain, movement disorders, incontinence, and other conditions who could benefit from neuromodulation therapy. Due to this Medtronics seeks to deliver real-time data to the patients and the physicians so they effectively find the cure for the tracked symptoms.
Abbott:
Headquartered in Illinois, USA, Abbott focuses on discovery, development, manufacture, and sale of health care products. The company operates through four segments namely, established pharmaceutical products, diagnostic products, nutritional products, and vascular products. Additionally, the company has two non-reportable segments, namely, diabetes care and medical optics. The diabetes care division of the company is located in California, U.S. and provides blood glucose meters, blood glucose test strips, sensors, data management decision software, and accessories.
June, 2017: Alere shareholders approve amended merger with Abbott. This merger will further strengthen the global presence of the company.
October, 2016 : Abbott announced collaborations with Celgene and Agios for diagnostic identification of IDH mutations. The agreement focuses on the development and commercialize the diagnostic tests.
April, 2016: Abbott received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.
Siemens:
Siemens is a leading global healthcare company continuously developing their portfolio from medical imaging and laboratory diagnostics to adding managed services, consulting, and healthcare IT services apart from further technologies for therapeutic and molecular diagnostics.
September, 2016: Siemens launched the combination of the Modularis urological shock wave unit and the flat detector technology of the mobile C-arm Cios Fusion. Since, constantly switching between two or even three different control units would be complicated and could lead to errors, the Modularis' central control unit is a better option. This will help Siemens to strengthen its position in the market.
Ask to Expert @ https://www.marketresearchfuture.com/enquiry/2792 .
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Electrochemical Biosensors Market Size, Status and Forecast 2025; by Application and End User here
News-ID: 896198 • Views: …
More Releases from Market Research Future
Intelligent Process Automation Market to Reach USD 30 Billion by 2035, Growing a …
The Intelligent Process Automation Market is poised for sustained expansion, with its value rising from USD 8.99 billion in 2024 to USD 30.0 billion by 2035. This growth reflects a strong compound annual growth rate (CAGR) of 11.58% between 2025 and 2035.
Intelligent process automation combines robotic process automation, artificial intelligence, natural language processing, and machine learning to create adaptive, efficient, and resilient business processes. Its adoption is accelerating as…
Chinese Language Education for K-12 Market to Grow at 12.8% CAGR, Hitting USD 16 …
The Chinese Language Education for K-12 Market is experiencing robust expansion as global interest in Chinese language proficiency continues to rise. According to Market Research Future, the market size was valued at USD 4,400.48 million in 2024 and is projected to grow from USD 4,941.74 million in 2025 to USD 16,612.10 million by 2035. This trajectory reflects a strong compound annual growth rate (CAGR) of 12.8% during the forecast period…
Computer Aided Engineering Market to Reach USD 28.78 Billion by 2035, Growing at …
The Computer Aided Engineering Market is entering a decade of strong expansion, underpinned by the growing demand for simulation technologies, design optimization, and advanced product development across industries. According to Market Research Future, the Computer Aided Engineering Market was valued at USD 11.09 billion in 2024 and is projected to grow from USD 11.83 billion in 2025 to USD 28.78 billion by 2035, reflecting a robust compound annual growth rate…
B2B Cybersecurity Market to Hit USD 29.52 Billion by 2034, Growing at 14.32% CAG …
As per Market Research Future Analysis, the B2B Cybersecurity Market is set for remarkable expansion, projected to grow from USD 8,853.54 Million in 2025 to USD 29,527.37 Million by 2034, achieving a compound annual growth rate (CAGR) of 14.32% during the forecast period. The market was valued at USD 7,744.50 Million in 2024, demonstrating a strong base of demand driven by the rising frequency of cyberattacks, growing regulatory pressure, and…
More Releases for Roche
Germany Hepatitis C Testing Market Size, Trends, Growth, Opportunities (2024-203 …
The dental handpiece market was valued at USD 106.8 million in 2019 and is projected to grow from USD 80.1 million in 2020 to USD 121.4 million in 2027, recording a CAGR of 6.1% during the forecast period (2024-2032).
The Germany Hepatitis C Testing Market continues to grow as public health initiatives and advanced diagnostics play a pivotal role in managing the hepatitis C virus (HCV) epidemic. Germany's healthcare infrastructure is…
Atezolizumab Market Size, Growth Opportunities 2031 by Key Manufacturer- Genente …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Reports analysis, the global Atezolizumab Market size was valued at USD 2.68 Billion in 2023 and is expected to reach USD 7.86 Billion by the end of 2031 with a CAGR of 16.6% During the Forecast Period 2023-2031.
The Atezolizumab Market presents significant opportunities driven by advancements in immuno-oncology, the growing prevalence of cancer, and the increasing demand for targeted cancer therapies. Atezolizumab is…
Biomarker Testing Market | Agilent Technologies, Roche, ,
The global biomarker testing market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the biomarker testing market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Tumor Immunotherapy Market 2023 Comprehensive Analysis - AstraZeneca, Pfizer Inc …
Global Tumor Immunotherapy Market 2023 is the fresh report by Fior Markets that is formulated with the exact understanding of customer requirements. The report covers comprehensive market analysis, evaluation of findings, as well as assumptions taken from a variety of sources. The research report offers an in-depth look at the service providers operating in the global Tumor Immunotherapy market. According to the analyst, the market is going through a large…
Tecentriq Market Analysis & Forecast 2021 - 2027|Roche, ,
Complete study of the global Tecentriq market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Tecentriq industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also provided accurate…
PEGylated Protein Therapeutics Market Competitive Analysis | Amgen, AstraZeneca, …
PEGylated Protein Therapeutics Market analysis document helps identify the latest growths, market shares, and policies employed by the major market players. In addition, this market study affirms the leading players across the globe in the PEGylated Protein Therapeutics Market and their key marketing dispositions and advertising enterprise have been highlighted to offer a clear understanding of the market. The major topics of this document can be listed as; Overview of…
